Evaluation of liver support systems for preclinical testing by animal trials

Artificial Organs

Volumn 30, Issue 10, 2006, Pages 815-821

  Seleverstov, Oleksandr ^a   Bader, Augustinus ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Animal disease models; Artificial liver; Evaluation studies; Liver failure; Review

Indexed keywords

ARTIFICIAL ORGANS; SOFTWARE TESTING;

ANIMAL DISEASE; ANIMAL DISEASE MODEL; ANIMAL MODEL; ANIMAL TRIALS; ARTIFICIAL LIVER; DISEASE MODELS; EVALUATION STUDY; LIVER FAILURE; PRE-CLINICAL TESTING; SUPPORT SYSTEMS;

ANIMALS;

ANATOMICAL VARIATION; CLINICAL OBSERVATION; CONFERENCE PAPER; DISEASE MODEL; EVALUATION; HUMAN; ISCHEMIA; LIVER FAILURE; LIVER SUPPORT; LIVER TRANSPLANTATION; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; REPERFUSION; STANDARDIZATION; SURGICAL TECHNIQUE;

ANIMALIA;

EID: 33749490178     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2006.00305.x     Document Type: Conference Paper

References (88)

1. Fruehauf NR, Oldhafer KJ, Westermann S, Sotiropoulos GC, Kaiser GM. Acute hepatic failure in swine: hepatectomy versus vascular occlusion. J Invest Surg 2004;17:163-71.
2. Hunter RJ, Patel VB, Baker AJ, Preedy VR. Liver dysfunction induced by bile duct ligation and galactosamine injection alters cardiac protein synthesis. Metabolism 2004;53:964-8.
3. Koniaris LG, Zimmers-Koniaris T, Hsiao EC, Chavin K, Sitzmann JV, Farber JM. Cytokineresponsive gene-2/ifn-inducible protein-10 expression in multiple models of liver and bile duct injury suggests a role in tissue regeneration. J Immunol 2001;167:399-406.
4. Kusmic C, Boggi U, Bellini R, et al. Oxidative stress in fulminant hepatic failure: comparison of two pig models with and without liver necrosis. Hepatogastroenterology 2001;48:762-9.
5. Theodoraki K, Kostopanagiotou G, Smyrniotis V, et al. Haemodynamic changes in ischaemic vs. anhepatic pig experimental model of acute liver failure. Eur J Anaesthesiol 2002;19:40-6.
6. Tonnesen K. Experimental liver failure: a comparison between hepatectomy and hepatic devascularization in the pig. Acta Chir Scand 1977;143:271-7.
7. Terblanche J, Hickman R. Animal models of fulminant hepatic failure. Dig Dis Sci 1991;36:770-4.
8. Desille M, Mahler S, Seguin P, et al. Reduced encephalopathy in pigs with ischemia-induced acute hepatic failure treated with a bioartificial liver containing alginate entrapped hepatocytes. Crit Care Med 2002;30:658-63.
9. Ho DW, Fan ST, To J, et al. Selective plasma filtration for treatment of fulminant hepatic failure induced by D-galactosamine in a pig model. Gut 2002;50:869-76.
10. Kamohara Y, Fujioka H, Eguchi S, Kawashita Y, Furui J, Kanematsu T. Comparative study of bioartificial liver support and plasma exchange for treatment of pigs with fulminant hepatic failure. Artif Organs 2000;24:265-70.
11. Ryan CJ, Anilkumar T, Ben-Hamida AJ, et al. Multisorbent plasma perfusion in fulminant hepatic failure: effects of duration and frequency of treatment in rats with grade iii hepatic coma. Artif Organs 2001;25:109-18.
12. Sosef MN, Abrahamse LS, van de Kerkhove MP, Hartman R, Chamuleau RA, van Gulik TM. Assessment of the amc-bioartificial liver in the anhepatic pig. Transplantation 2002;73:204-9.
13. Suh KS, Lilja H, Kamohara Y, et al. Bioartificial liver treatment in rats with fulminant hepatic failure: effect on DNA-binding activity of liver-enriched and growth-associated transcription factors. J Surg Res 1999;85:243-50.
14. Jalan R, Sen S, Williams R. Prospects for extracorporeal liver support. Gut 2004;53:890-8.
15. Mullin EJ, Metcalfe MS, Maddern GJ. Artificial liver support: potential to retard regeneration? Arch Surg 2004;139:670-7.
16. Demetriou AA, Brown RS, Busuttil RW, et al. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 2004;239:660-7;discussion 667-70.
17. van de Kerkhove MP, Hoekstra R, Chamuleau RA, van Gulik TM. Clinical application of bioartificial liver support systems. Ann Surg 2004;240:216-30.
18. Du WB, Li LJ, Huang JR, et al. Effects of artificial liver support system on patients with acute or chronic liver failure. Transplant Proc 2005;37:4359-64.
19. Cornelius CE, Himes JA, Gronwall RR. Experimental liver diseases. Methods Achiev Exp Pathol 1975;7:22-55.
20. Filipponi F, Mosca F. Animal models of fulminant hepatic failure: need to test liver support devices. Dig Liver Dis 2001;33:607-13.
21. Gorini P, Fogli L, Morsiani E. [Acute and fulminant liver failure: experimental models]. Ann Ital Chir 2000;71:293-300.
22. Newsome PN, Plevris JN, Nelson LJ, Hayes PC. Animal models of fulminant hepatic failure: a critical evaluation. Liver Transpl 2000;6:21-31.
23. Slapak M. Fulminant liver failure: clinical and experimental study. Ann R Coll Surg Engl 1975;57:234-47.
24. Takada Y, Ishiguro S, Fukunaga K. Large-animal models of fulminant hepatic failure. J Artif Organs 2003;6:9-13.
25. van de Kerkhove MP, Hoekstra R, van Gulik TM, Chamuleau RA. Large animal models of fulminant hepatic failure in artificial and bioartificial liver support research. Biomaterials 2004;25:1613-25.
26. Cuervas-Mons V, Colas A, Rivera JA, Prados E. In vivo efficacy of a bioartificial liver in improving spontaneous recovery from fulminant hepatic failure: a controlled study in pigs. Transplantation 2000;69:337-44.
27. Kramer L. Acute liver failure. Wien Klin Wochenschr 2004;116:67-81.
28. Ascher NL, Lake JR, Emond JC, Roberts JP. Liver transplantation for fulminant hepatic failure. Arch Surg 1993;128:677-82.
29. Gow PJ, Jones RM, Dobson JL, Angus PW. Etiology and outcome of fulminant hepatic failure managed at an Australian liver transplant unit. J Gastroenterol Hepatol 2004;19:154-9.
30. Jaeck D, Boudjema K, Audet M, et al. Auxiliary partial orthotopic liver transplantation (apolt) in the treatment of acute liver failure. J Gastroenterol 2002;37(Suppl. 13):88-91.
31. Miwa S, Hashikura Y, Mita A, et al. Living-related liver transplantation for patients with fulminant and subfulminant hepatic failure. Hepatology 1999;30:1521-6.
32. Bassett SE, Di Bisceglie AM, Bacon BR, et al. Effects of iron loading on pathogenicity in hepatitis c virus-infected chimpanzees. Hepatology 1999;29:1884-92.
33. Lukashevich IS, Tikhonov I, Rodas JD, et al. Arenavirus-mediated liver pathology: acute lymphocytic choriomeningitis virus infection of rhesus macaques is characterized by high-level interleukin-6 expression and hepatocyte proliferation. J Virol 2003;77:1727-37.
34. Pinto MA, Marchevsky RS, Pelajo-Machado M, et al. Inducible nitric oxide synthase (inos) expression in liver and splenic t lymphocyte rise are associated with liver histological damage during experimental hepatitis a virus (hav) infection in callithrix jacchus. Exp Toxicol Pathol 2000;52:3-10.
35. Fan C, Li Q, Zhang Y, et al. I kappa b alpha and I kappa b beta possess injury context-specific functions that uniquely influence hepatic nfkappab induction and inflammation. J Clin Invest 2004;113:746-55.
36. Fuentealba IC, Aburto EM. Animal models of copper-associated liver disease. Comp Hepatol 2003;doi:10.1186/1476-5926-2-5.
37. Pawlikowska L, Groen A, Eppens EF, et al. A mouse genetic model for familial cholestasis caused by atp8b1 mutations reveals perturbed bile salt homeostasis but no impairment in bile secretion. Hum Mol Genet 2004;13:881-92.
38. Omokawa S, Arai Y, Saito H, et al. A simple experimental model of total hepatectomy, hepatic ischemia and extrahepatic portal obstruction in rats using splenic transposition. Jpn J Surg 1991;21:50-6.
39. Xu QX, Ding YT, Qiu YD, Yu DC, Zhang HY. A reliable graded acute liver failure model in rats: treatment with internal bioartificial liver. Hepatobiliary Pancreat Dis Int 2004;3:254-8.
40. Ueno S, Kashimoto T, Susa N, et al. Comparison of hepatotoxicity and metabolism of butyltin compounds in the liver of mice, rats and guinea pigs. Arch Toxicol 2003;77:173-81.
41. Michalopoulos GK, DeFrances MC. Liver regeneration. Science 1997;276:60-6.
42. Werlich T, Stiller KJ, Machnik G. Experimental studies on the stem cell concept of liver regeneration. i. Exp Toxicol Pathol 1998;50:73-7.
43. Zajicek G, Arber N, Schwartz-Arad D. Streaming liver. VIII. Cell production rates following partial hepatectomy. Liver 1991;11:347-51.
44. Ferko A, Plodr M, Dobes D, Subrt Z. [Sharp transsection of the parenchyma in liver resection]. Rozhl Chir 2003;82:407-12.
45. Topp SA, McClurken M, Lipson D, et al. Saline-linked surface radiofrequency ablation: factors affecting steam popping and depth of injury in the pig liver. Ann Surg 2004;239:518-27.
46. Koyama S, Sato Y, Hatakeyama K. The subcutaneous splenic transposition prevents liver injury induced by excessive portal pressure aftermassive hepatectomy. Hepatogastroenterology 2003;50:37-42.
47. Lemaire LC, vanWagensveld BA, van Gulik TM, Dankert J, van Lanschot JJ, Gouma DJ. Bacterial translocation to the thoracic duct in a setting of ischemia, partial resection and reperfusion of the porcine liver. Dig Surg 1999;16:222-8.
48. Sun L, Chow PK, Fook-Chong SM, Chew M, Aw SE, Soo KC. Liver regeneration after partial hepatectomy is non-uniform: flow cytometric bromodeoxyuridine incorporation and cell cycle studies in a porcine model. Res Exp Med (Berl) 1999;198:229-36.
49. Ryska M, Kieslichova E, Pantoflicek T, et al. Devascularization surgical model of acute liver failure in minipigs. Eur Surg Res 2004;36:179-84.
50. Nagashima I, Bergmann L, Alsina AE, Schweizer RT. Auxiliary heterotopic partial liver transplantation in pigs with acute ischemic liver failure. Hepatogastroenterology 1997;44:1426-31.
51. Ishiguro S, Takada Y, Gu M, et al. Auxiliary partial orthotopic liver transplantation for fulminant hepatitis: regeneration of the diseased native liver in a pig model. Transplantation 2003;75:1901-4.
52. Court FG, Laws PE, Morrison CP, et al. Subtotal hepatectomy: a porcine model for the study of liver regeneration. J Surg Res 2004;116:181-6.
53. Kahn D, Hickman R, Terblanche J, von Sommoggy S. Partial hepatectomy and liver regeneration in pigs-the response to different resection sizes. J Surg Res 1988;45:176-80.
54. Fruehauf NR, Oldhafer KJ, Hoeltje M, et al. A bioartificial liver support system using primary hepatocytes: a preclinical study in a new porcine hepatectomy model. Surgery 2004;136:47-56.
55. Miller DJ, Hickman R, Fratter R, Terblanche J, Saunders SJ. An animal model of fulminant hepatic failure: a feasibility study. Gastroenterology 1976;71:109-13.
56. Pastor CM, Hadengue A, Nussler AK. Minor involvement of nitric oxide during chronic endotoxemia in anesthetized pigs. Am J Physiol Gastrointest Liver Physiol 2000;278:G416-24.
57. Skawran S, Palmes D, Budny T, Bahde R, Stratmann U, Spiegel HU. Development and evaluation of an experimental model for investigating the pathogenesis and therapeutic strategies of acute liver failure. Transplant Proc 2003;35:3142-6.
58. Kelly JH, Koussayer T, He DE, et al. An improved model of acetaminophen-induced fulminant hepatic failure in dogs. Hepatology 1992;15:329-35.
59. Neff SB, Neff TA, Kunkel SL, Hogaboam CM. Alterations in cytokine/chemokine expression during organ-to-organ communication established via acetaminophen-induced toxicity. Exp Mol Pathol 2003;75:187-93.
60. Scorticati C, Prestifilippo JP, Eizayaga FX, et al. Hyperammonemia, brain edema and blood-brain barrier alterations in prehepatic portal hypertensive rats and paracetamol intoxication. World J Gastroenterol 2004;10:1321-4.
61. Nieuwoudt M, Kunnike R, Smuts M, et al. Standardization criteria for an ischemic surgical model of acute hepatic failure in pigs. Biomaterials 2006;27:3836-45.
62. Ito Y, Eguchi S, Kamohara Y, et al. Influence of serum from rats with fulminant hepatic failure on hepatocytes in a bioartificial liver system. Int J Artif Organs 2004;27:303-10.
63. Tsutsui H, Adachi K, Seki E, Nakanishi K. Cytokine-induced inflammatory liver injuries. Curr Mol Med 2003;3 (6):545-59.
64. Benoist S, Sarkis R, Baudrimont M, et al. A reversible model of acute hepatic failure by temporary hepatic ischemia in the pig. J Surg Res 2000;88:63-9.
65. Filipponi F, Boggi U, Meacci L, et al. A new technique for total hepatectomy in the pig for testing liver support devices. Surgery 1999;125:448-55.
66. Brown JB, Emerick KM, Brown DL, Whitington PF, Alonso EM. Recombinant factor viia improves coagulopathy caused by liver failure. J Pediatr Gastroenterol Nutr 2003;37:268-72.
67. Egbring R, Seitz R. Improved prognosis of fulminant hepatic failure (fhf) after plasma derivative replacement therapy. Enhanced proteolysis of hemostatic proteins confirmed by proteinase-inhibitor complexes determination. Z Gastroenterol 1990;28:104-9.
68. Shami VM, Caldwell SH, Hespenheide EE, Arseneau KO, Bickston SJ, Macik BG. Recombinant activated factor vii for coagulopathy in fulminant hepatic failure compared with conventional therapy. Liver Transpl 2003;9:138-43.
69. Arkadopoulos N, Chen SC, Khalili TM, et al. Transplantation of hepatocytes for prevention of intracranial hypertension in pigs with ischemic liver failure. Cell Transplant 1998;7:357-63.
70. Aoi T. [Influence of enteral nutrition on hepatic regeneration and small intestinal epithelium after hepatectomy in rat-comparative assessment with tpn]. Nippon Geka Gakkai Zasshi 1995;96:295-300.
71. Ikuta K, Mishina Y, Nimura Y, Shionoya S, Usukura J, Wakabayashi T. Effect of lipid emulsions for total parenteral nutrition on regeneration of the liver after partial hepatectomy in rats. Nutrition 1995;11:365-70.
72. Ok E, Yilmaz Z, Karakuecuek I, Akguen H, Sahin H. Use of olive oil based emulsions as an alternative to soybean oil based emulsions in total parenteral nutrition and their effects on liver regeneration following hepatic resection in rats. Ann Nutr Metab 2003;47:221-7.
73. Miyamoto S, Eguchi S, Sugiyama N, et al. Hepatic expression and serum levels of thrombomodulin reflect the extent of liver injury in rats with fulminant hepatic failure and extensive hepatectomy. Hepatol Res 2002;22:206-13.
74. Sosef MN, Van De Kerkhove MP, Abrahamse SL, Levi MM, Chamuleau RA, Van Gulik TM. Blood coagulation in anhepatic pigs: effects of treatment with the amc-bioartificial liver. J Thromb Haemost 2003;1:511-5.
75. Ytrebo LM, Nedredal GI, Langbakk B, Revhaug A. An experimental large animal model for the assessment of bioartificial liver support systems in fulminant hepatic failure. Scand J Gastroenterol 2002;37:1077-88.
76. Kieslichova E, Ryska M, Pantoflicek T, Ryska O, Zazula R, Skobova J. Hemodynamic parameters in a surgical devascularization model of fulminant hepatic failure in the minipig. Physiol Res 2005;54:485-90.
77. Nagaki M, Miki K, Kim YI, et al. Development and characterization of a hybrid bioartificial liver using primary hepatocytes entrapped in a basement membrane matrix. Dig Dis Sci 2001;46:1046-56.
78. Hotta T, Kobayashi Y, Taniguchi K, et al. Liver functional analysis by total bile acid level of C-tube bile after hepatectomy. Hepatogastroenterology 2005;52:1211-5.
79. Shimahara Y, Terajima H, Ikai I, Yamaoka Y. Aspects of our liver support systems using extracorporeal xenoperfusion of pig or baboon liver: review. J Hepatobiliary Pancreat Surg 2001;8:27-39.
80. Mets B, Hickman R, Allin R, Van Dyk J, Lotz Z. Effect of hypoxia on the hepaticmetabolism of lidocaine in the isolated perfused pig liver. Hepatology 1993;17:668-76.
81. Matsuyama K, Fukuda Y, Miyake H, Yogita S, Tashiro S. Experimental study of the evaluation of liver function on the opposite side during portacaval anastomosis and ligation of the left portal branch. J Med Invest 2004;51:84-95.
82. Aoki M, Ishii Y, Ito A, Khono T, Takayama T. Phenylalanine breath test as a method to evaluate hepatic dysfunction in obstructive jaundice. J Surg Res 2006;130:119-23.
83. Black D, Lyman S, Heider TR, Behrns KE. Molecular and cellular features of hepatic regeneration. J Surg Res 2004;117:306-15.
84. Ramadori G, Armbrust T. Cytokines in the liver. Eur J Gastroenterol Hepatol 2001;13:777-84.
85. Schmidt CF, Bladt S, Goedecke Brinkmann V, et al. Scatter factor/hepatocyte growth factor is essential for liver development. Nature 1995;373:699-702.
86. Tomiya T, Tani M, Yamada S, Hayashi S, Umeda N, Fujiwara K. Serum hepatocyte growth factor levels in hepatectomized and nonhepatectomized surgical patients. Gastroenterology 1992;103:1621-4.
87. Chow PK, Jeyaraj P, Tan SY, Cheong SF, Soo KC. Serial ultrasound guided percutaneous liver biopsy in a partial hepatectomy porcine model: a new technique in the study of liver regeneration. J Surg Res 1997;70:134-7.
88. Pennisi PA, Kopchick JJ, Thorgeirsson S, LeRoith D, Yakar S. Role of growth hormone (gh) in liver regeneration. Endocrinology 2004;145:4748-55.